See more : Constellation Pharmaceuticals, Inc. (CNST) Income Statement Analysis – Financial Results
Complete financial analysis of Elegant Floriculture & Agrotech (India) Limited (ELEFLOR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Elegant Floriculture & Agrotech (India) Limited, a leading company in the Industrial – Distribution industry within the Industrials sector.
You may be interested
- JPMorgan China Growth & Income plc (JCGI.L) Income Statement Analysis – Financial Results
- Mallcom (India) Limited (MALLCOM.BO) Income Statement Analysis – Financial Results
- Sharc International Systems Inc. (INTWF) Income Statement Analysis – Financial Results
- Gobi Acquisition Corp. (GOBI) Income Statement Analysis – Financial Results
- IZMO Limited (IZMO.BO) Income Statement Analysis – Financial Results
Elegant Floriculture & Agrotech (India) Limited (ELEFLOR.BO)
Industry: Industrial - Distribution
Sector: Industrials
About Elegant Floriculture & Agrotech (India) Limited
Elegant Floriculture & Agrotech (India) Ltd. engages in the business of exporting roses and other flowers. Its products include indoor plants, Dutch roses, and gerbera flowers. The company was founded on September 9, 1993 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.01M | 7.79M | 7.59M | 5.35M | 9.97M | 16.69M | 12.51M | 19.63M | 15.41M | 13.05M | 7.68M | 7.26M | 6.65M | 3.67M | 13.41M | 1.06M |
| Cost of Revenue | 3.47M | 4.36M | 3.82M | 2.65M | 5.51M | 6.29M | 5.34M | 6.40M | 8.18M | 5.35M | 4.76M | 2.86M | 2.76M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.54M | 3.43M | 3.76M | 2.71M | 4.46M | 10.40M | 7.17M | 13.23M | 7.22M | 7.71M | 2.92M | 4.40M | 3.89M | 3.67M | 13.41M | 1.06M |
| Gross Profit Ratio | 42.22% | 44.01% | 49.62% | 50.57% | 44.74% | 62.30% | 57.32% | 67.41% | 46.88% | 59.04% | 38.03% | 60.59% | 58.44% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 579.48K | 1.20M | 640.66K | 776.39K | 616.00K | 2.56M | 451.39K | 519.43K | 888.46K | 67.49K | 0.00 | 1.65M | 2.63M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 40.80K | 36.90K | 22.64K | 36.69K | 55.19K | 25.86K | 48.23K | 590.47K | 48.68K | 85.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 620.28K | 1.24M | 663.30K | 813.08K | 671.19K | 2.59M | 499.63K | 1.11M | 937.13K | 153.11K | 0.00 | 1.65M | 2.63M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 1.92M | 1.52K | 151.43K | 1.00 | 217.92K | -2.50K | -10.47K | 389.45K | 151.64K | 246.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.54M | 10.41M | 8.85M | 7.58M | 9.13M | 13.62M | 9.14M | 11.98M | 7.40M | 7.82M | 1.89M | 3.51M | 3.19M | 2.72M | 12.71M | 764.00K |
| Cost & Expenses | 11.13M | 14.77M | 12.67M | 10.22M | 14.64M | 19.91M | 14.48M | 18.37M | 15.58M | 13.16M | 6.65M | 6.38M | 5.95M | 2.72M | 12.71M | 764.00K |
| Interest Income | 5.36M | 5.14M | 7.35M | 4.53M | 5.85M | 4.32M | 4.03M | 4.12M | 1.13M | 2.32M | 0.00 | 713.92K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.04K | 43.95K | 494.64K | 670.16K | 824.78K | 839.99K | 918.34K | 1.30M | 948.96K | 690.81K | 0.00 | 730.48K | 0.00 | 441.00K | 481.00K | 104.00K |
| Depreciation & Amortization | 3.76M | 4.34M | 4.29M | 4.33M | 4.39M | 4.38M | 4.36M | 4.33M | 3.72M | 3.58M | 3.30M | 3.27M | 3.15M | 2.99M | 2.78M | 2.78M |
| EBITDA | 4.00M | 2.59M | 6.70M | 3.98M | 5.81M | 5.47M | 6.67M | 10.85M | 4.70M | 6.04M | 4.33M | 4.16M | 3.85M | 3.94M | 3.49M | 3.08M |
| EBITDA Ratio | 66.52% | 33.77% | 88.20% | 73.76% | 57.67% | 32.47% | 51.22% | 59.80% | 31.29% | 45.16% | 47.25% | 57.28% | 57.92% | 107.36% | 26.00% | 289.92% |
| Operating Income | -5.11M | -6.89M | -4.94M | -4.87M | -4.67M | -3.22M | -1.97M | 357.32K | -135.78K | 1.38M | 1.49M | 158.00K | 246.00K | 507.00K | 225.00K | 194.00K |
| Operating Income Ratio | -85.01% | -88.40% | -65.14% | -90.99% | -46.85% | -19.26% | -15.77% | 1.82% | -0.88% | 10.59% | 19.34% | 2.18% | 3.70% | 13.83% | 1.68% | 18.27% |
| Total Other Income/Expenses | 5.35M | 5.09M | 7.00M | 3.82M | 5.20M | 3.42M | 3.32M | 3.96M | 325.33K | 246.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 236.07K | -1.76M | 1.91M | -1.05M | 528.51K | 200.91K | 1.35M | 5.21M | 150.82K | 1.63M | 1.49M | 158.00K | 246.00K | 507.00K | 225.00K | 194.00K |
| Income Before Tax Ratio | 3.93% | -22.56% | 25.19% | -19.65% | 5.30% | 1.20% | 10.81% | 26.55% | 0.98% | 12.48% | 19.34% | 2.18% | 3.70% | 13.83% | 1.68% | 18.27% |
| Income Tax Expense | 66.24K | -508.84K | 520.85K | 3.48M | 1.78M | 1.22M | 1.02M | -4.01M | -25.57K | -691.81K | 592.00K | 2.43M | 47.00K | 441.00K | 481.00K | 6.00K |
| Net Income | 169.83K | -1.25M | 1.39M | -4.53M | -1.25M | -1.02M | 332.17K | 9.22M | 176.39K | 2.32M | 893.00K | -2.28M | 199.00K | 507.00K | 225.00K | 188.00K |
| Net Income Ratio | 2.82% | -16.03% | 18.32% | -84.62% | -12.58% | -6.09% | 2.66% | 46.97% | 1.14% | 17.78% | 11.63% | -31.33% | 2.99% | 13.83% | 1.68% | 17.70% |
| EPS | 0.01 | -0.06 | 0.07 | -0.23 | -0.06 | -0.05 | 0.02 | 0.46 | 0.01 | 0.12 | 0.04 | -0.11 | 0.01 | 0.33 | 0.03 | 0.03 |
| EPS Diluted | 0.01 | -0.06 | 0.07 | -0.23 | -0.06 | -0.05 | 0.02 | 0.46 | 0.01 | 0.12 | 0.04 | -0.11 | 0.01 | 0.33 | 0.03 | 0.03 |
| Weighted Avg Shares Out | 16.98M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M | 19.34M | 22.33M | 20.00M | 19.90M | 15.37M | 7.50M | 6.06M |
| Weighted Avg Shares Out (Dil) | 16.98M | 20.00M | 20.00M | 20.00M | 20.00M | 20.33M | 20.00M | 20.00M | 20.00M | 19.34M | 22.33M | 20.00M | 19.90M | 15.37M | 7.50M | 6.06M |
No news found for: ELEFLOR.BO
Source: https://incomestatements.info
Category: Stock Reports